IJMS | Free Full-Text | YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis | BMC Cancer | Full Text
Cholangiocarcinoma display features of a neuroendocrine tumor.... | Download Scientific Diagram
CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients - Liu - 2018 - Journal of Surgical Oncology - Wiley Online Library
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology
How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect
Cancers | Free Full-Text | Histological Heterogeneity of Primary Liver Cancers: Clinical Relevance, Diagnostic Pitfalls and the Pathologist's Role
Cancers | Free Full-Text | Pathology of Combined Hepatocellular Carcinoma- Cholangiocarcinoma: An Update
Pathologic differential diagnosis of metastatic carcinoma in the liver
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations - ScienceDirect
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology
The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type | Journal of Clinical Pathology
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine | Full Text
Cholangiocarcinoma | Nature Reviews Gastroenterology & Hepatology
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | Gut
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features | Modern Pathology
Combined hepatocellular-cholangiocarcinoma: An update - ScienceDirect
Inhibin-Positive “Cholangioblastic” Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature - Ahmed Bakhshwin, Keith K. Lai, Alwalid Ammoun, Kenneth Friedman, Mohamed El Hag, 2023
Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis - ScienceDirect
IJMS | Free Full-Text | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
The Utility of Keratin 903 as a New Prognostic Marker in Mass-Forming-Type Intrahepatic Cholangiocarcinoma | Modern Pathology
Cytokeratin | Welcome to QC Mark
Biomedicines | Free Full-Text | Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
The Utility of Keratin 903 as a New Prognostic Marker in Mass-Forming-Type Intrahepatic Cholangiocarcinoma | Modern Pathology
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells | Scientific Reports
